Germany · Delayed Price · Currency is EUR Gaush Meditech Statistics
Total Valuation
Gaush Meditech has a market cap or net worth of EUR 135.98 million. The enterprise value is 147.64 million.
| Market Cap | 135.98M |
| Enterprise Value | 147.64M |
Important Dates
The last earnings date was Friday, August 22, 2025.
| Earnings Date | Aug 22, 2025 |
| Ex-Dividend Date | Jun 23, 2025 |
Share Statistics
| Current Share Class | 145.33M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.77% |
| Shares Change (QoQ) | -1.13% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 50.06M |
Valuation Ratios
The trailing PE ratio is 11.23.
| PE Ratio | 11.23 |
| Forward PE | n/a |
| PS Ratio | 0.79 |
| PB Ratio | 0.68 |
| P/TBV Ratio | 3.27 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 12.19 |
| EV / Sales | 0.85 |
| EV / EBITDA | 5.55 |
| EV / EBIT | 7.49 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.40, with a Debt / Equity ratio of 0.28.
| Current Ratio | 2.40 |
| Quick Ratio | 1.28 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | 2.12 |
| Debt / FCF | n/a |
| Interest Coverage | 6.16 |
Financial Efficiency
Return on equity (ROE) is 6.03% and return on invested capital (ROIC) is 4.75%.
| Return on Equity (ROE) | 6.03% |
| Return on Assets (ROA) | 3.81% |
| Return on Invested Capital (ROIC) | 4.75% |
| Return on Capital Employed (ROCE) | 7.68% |
| Revenue Per Employee | 208,907 |
| Profits Per Employee | 14,788 |
| Employee Count | 884 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 2.11 |
Taxes
In the past 12 months, Gaush Meditech has paid 7.94 million in taxes.
| Income Tax | 7.94M |
| Effective Tax Rate | 40.65% |
Stock Price Statistics
The stock price has decreased by -22.84% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -22.84% |
| 50-Day Moving Average | 0.80 |
| 200-Day Moving Average | 0.87 |
| Relative Strength Index (RSI) | 57.79 |
| Average Volume (20 Days) | 110 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Gaush Meditech had revenue of EUR 171.09 million and earned 12.11 million in profits. Earnings per share was 0.08.
| Revenue | 171.09M |
| Gross Profit | 79.79M |
| Operating Income | 19.52M |
| Pretax Income | 19.52M |
| Net Income | 12.11M |
| EBITDA | 26.32M |
| EBIT | 19.52M |
| Earnings Per Share (EPS) | 0.08 |
Balance Sheet
The company has 45.60 million in cash and 55.75 million in debt, giving a net cash position of -10.15 million.
| Cash & Cash Equivalents | 45.60M |
| Total Debt | 55.75M |
| Net Cash | -10.15M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 199.12M |
| Book Value Per Share | 1.36 |
| Working Capital | 72.39M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 46.63%, with operating and profit margins of 11.41% and 7.08%.
| Gross Margin | 46.63% |
| Operating Margin | 11.41% |
| Pretax Margin | 11.41% |
| Profit Margin | 7.08% |
| EBITDA Margin | 15.38% |
| EBIT Margin | 11.41% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 3.70%.
| Dividend Per Share | 0.03 |
| Dividend Yield | 3.70% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 0.77% |
| Shareholder Yield | 4.48% |
| Earnings Yield | 8.91% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |